Skip to content
10-Q

Quarterly Report

Raptor Pharmaceutical Corp

0001140361-15-039839

← back to feed
Filed
Nov 5, 2015 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Capex Q3 2015 · Sep 30, 2015 $2.47M
Capex Q3 2015 · Sep 30, 2014 $4.26M
Long Term Debt Q3 2015 · Sep 30, 2015 $54M
Cash And Equivalents Q3 2015 · Sep 30, 2015 $207.64M
Cash And Equivalents Q3 2015 · Dec 31, 2014 $149.61M
Cash And Equivalents Q3 2015 · Sep 30, 2014 $114.68M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $83.05M
Stockholders Equity Q3 2015 · Sep 30, 2015 $110.7M
Stockholders Equity Q3 2015 · Dec 31, 2014 $48.95M
Current Liabilities Q3 2015 · Sep 30, 2015 $38.85M
Current Liabilities Q3 2015 · Dec 31, 2014 $29.12M
Total Liabilities Q3 2015 · Sep 30, 2015 $140.85M
Total Liabilities Q3 2015 · Dec 31, 2014 $140.12M
Current Assets Q3 2015 · Sep 30, 2015 $233.47M
Current Assets Q3 2015 · Dec 31, 2014 $171.61M
Total Assets Q3 2015 · Sep 30, 2015 $251.55M
Total Assets Q3 2015 · Dec 31, 2014 $189.07M
Rd Expense Q3 2015 · Sep 30, 2015 $14.64M
Rd Expense Q3 2015 · Sep 30, 2015 $43.07M
Rd Expense Q3 2015 · Sep 30, 2014 $9M
Rd Expense Q3 2015 · Sep 30, 2014 $29.63M
Net Income Q3 2015 · Sep 30, 2015 −$14.59M
Net Income Q3 2015 · Sep 30, 2015 −$48.22M
Net Income Q3 2015 · Sep 30, 2014 −$6.03M
Net Income Q3 2015 · Sep 30, 2014 −$33.62M
Operating Income Q3 2015 · Sep 30, 2015 −$11.18M
Operating Income Q3 2015 · Sep 30, 2015 −$34.8M
Operating Income Q3 2015 · Sep 30, 2014 −$4.23M
Operating Income Q3 2015 · Sep 30, 2014 −$24.11M
Gross Profit Q3 2015 · Sep 30, 2015 $23.16M
Gross Profit Q3 2015 · Sep 30, 2015 $60.58M
Gross Profit Q3 2015 · Sep 30, 2014 $19.85M
Gross Profit Q3 2015 · Sep 30, 2014 $45.99M
Shares Outstanding restated Q3 2015 · Nov 4, 2014 851.1M sh